Trademark: 88787463
Status Date
Tuesday, September 1, 2020
Registration Number
6140677
Registration Date
Tuesday, September 1, 2020
Filing Date
Thursday, February 6, 2020
Published for Opposition
Tuesday, June 16, 2020
5 Pharmaceutical preparations for the treatment of neurological, renal, hematopoietic, thyroid, and ophthalmic diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Anti-inflammatory pharmaceutical preparations; Cardiovascular pharmaceuticals; anti-microbial pharmaceutical preparations; anti-neoplastic pharmaceutical preparations; immunomodulatory pharmaceutical preparations; hematopoietic pharmaceutical preparations; Pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations, namely, thrombolytic agents; antiplatelets, namely, platelet agglutination inhibitors and platelet aggregation inhibitors; Estrogen preparations; pharmaceutical preparations, namely, progestin; Androgen preparations; Antithyroid pharmaceutical preparations used to treat hyperthyroidism; Pharmaceutical preparations for treating diabetes; pharmaceutical preparations, namely, histamine H2 receptor antagonists and proton pump antagonists; anti-emetic pharmaceutical preparations; anti-convulsant pharmaceutical preparations; pharmaceutical preparations for the treatment of asthma; anti-diabetic pharmaceuticals
40 Custom manufacture of pharmaceuticals for others; providing technical information in the field of pharmaceutical manufacturing
42 Development of pharmaceutical preparations and medicines
Color is not claimed as a feature of the mark.
The mark consists of four rounded bars converging at the center at ninety-degree angles, each separated perpendicularly by circles in the spaces between the bars.
Sep 1, 2020
Registered-Principal Register
Jun 16, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 16, 2020
Published For Opposition
May 27, 2020
Notification Of Notice Of Publication E-Mailed
May 11, 2020
Assigned To Lie
Apr 30, 2020
Approved For Pub - Principal Register
Apr 30, 2020
Examiner's Amendment Entered
Apr 30, 2020
Notification Of Examiners Amendment E-Mailed
Apr 30, 2020
Examiners Amendment E-Mailed
Apr 30, 2020
Examiners Amendment -Written
Apr 29, 2020
Notification Of Priority Action E-Mailed
Apr 29, 2020
Priority Action E-Mailed
Apr 29, 2020
Priority Action Written
Apr 27, 2020
Assigned To Examiner
Feb 11, 2020
Notice Of Design Search Code E-Mailed
Feb 10, 2020
New Application Office Supplied Data Entered In Tram
Feb 10, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
